Clinical Trial

Atropine in the Treatment of Myopia Study in Malaysia

Name: Atropine in the Treatment of Myopia Study in Malaysia — clinical trial record (NCT07329777)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ATOM-MY

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This clinical trial is designed to assess the efficacy and safety of Atropine Sulphate 0.025% w/v Eye Drops compared to placebo in a randomized, double-blind, placebo-controlled study for the management of myopia progression in children.

Trial Details

NCT Number	NCT07329777
Lead Sponsor	IDB VisionCare SDN BHD Collaborators: Singapore National Eye Centre
Conditions	Myopia Progression
Enrollment	144 participants
Start Date	2025-09-17
Primary Completion	2027-09 (estimated)
Study Completion	2029-09 (estimated)
Updated on ClinicalTrials.gov	2026-01-09